Evidence map›Paper›PMID 32034027›Full record

ArticleBMJ open2020

RAPID-ADPKD (Retrospective epidemiological study of Asia-Pacific patients with rapId Disease progression of Autosomal Dominant Polycystic Kidney Disease): study protocol for a multinational, retrospective cohort study.

Hyunjin Ryu, Hayne C Park, Yun Kyu Oh, Irene Sangadi, Annette Wong, Changlin Mei, Tevfik Ecder, Angela Yee-Moon Wang, Tze-Wah Kao, Jenq-Wen Huang and 2 more

Open access · goldAbstract readClinical Trial Protocol
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 9 institutions in 6 countries.

Hyunjin RyuDepartment of Internal Medicine, Seoul National University Hospital, Seoul, Korea (the Republic of).
Hayne C ParkDepartment of Internal Medicine, Kangnam Sacred Heart Hospital, Seoul, Korea (the Republic of).
Yun Kyu OhDepartment of Internal Medicine, Seoul National University-Seoul Metropolitan Government Boramae Medical Center, Seoul, Korea (the Republic of).ORCID 0000-0001-8632-5743
Irene SangadiDepartment of Renal Medicine, Westmead Hospital, Western Sydney Local Health District, Westmead, New South Wales, Australia.
Annette WongDepartment of Renal Medicine, Westmead Hospital, Western Sydney Local Health District, Westmead, New South Wales, Australia.
Changlin MeiDepartment of Nephrology, Kidney Institute, Changzheng Hospital, Second Military Medical University, Shanghai, China.
Tevfik EcderDepartment of Internal Medicine, Istanbul Bilim Universitesi, Istanbul, Turkey.
Angela Yee-Moon WangDepartment of Internal Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong SAR, China.
Tze-Wah KaoDepartment of Internal Medicine, Fu Jen Catholic University Hospital, New Taipei City, Taiwan.
Jenq-Wen HuangDivision of Nephrology, National Taiwan University Hospital, Taipei, Taiwan.
Gopala K RanganDepartment of Renal Medicine, Westmead Hospital, Western Sydney Local Health District, Westmead, New South Wales, Australia.
Curie AhnDepartment of Internal Medicine, Seoul National University Hospital, Seoul, Korea (the Republic of) curie@snu.ac.kr.ORCID 0000-0001-7033-1102
Westmead Hospital · AUSeoul National University · KRFu Jen Catholic University · TWHallym University Kangnam Sacred Heart Hospital · KRIstanbul Bilim University · TRNational Taiwan University Hospital · TWQueen Mary Hospital · CNSecond Military Medical University · CNSeoul National University Hospital · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionPatients with autosomal dominant polycystic kidney disease (ADPKD) reach end-stage renal disease in their fifth decade on average. For effective treatment and early intervention, identifying subgroups with rapid disease progression is important in ADPKD. However, there are no epidemiological data on the clinical manifestations and disease progression of patients with ADPKD from the Asia-Pacific region. METHODS AND ANALYSIS: The RAPID-ADPKD ( ETHICS AND DISSEMINATION: This study was approved or is in the process of approval by the institutional review boards at each participating centre. The results will be presented in conferences and published in a journal, presenting data on the clinical characteristics, risk factors for disease progression and patterns of complications of ADPKD in Asian populations.

Indexed as

Disease ProgressionAdolescentAdultAustraliaChinaCross-Sectional StudiesGlomerular Filtration RateHong KongHumansKidneyMiddle AgedObservational Studies as TopicPolycystic Kidney, Autosomal DominantProspective StudiesRepublic of KoreaResearch DesignAsia-Pacific regionautosomal dominant polycystic kidney diseaseestimated glomerular filtration rateheight adjusted total kidney volumerapid progression

Identifiers

PMID32034027
PMCPMC7045131
OpenAlexW3005359335

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.